Viral Hepatitis in India

Clinics in Laboratory Medicine

Volumn 32, Issue 2, 2012, Pages 159-174

  Abraham, Priya ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Blood donor; India; Injection practices; Viral hepatitis; Water borne epidemics

Indexed keywords

ADEFOVIR; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ENTECAVIR; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS E ANTIBODY; HEPATITIS E VACCINE; IMMUNOGLOBULIN M ANTIBODY; LAMIVUDINE; PEGINTERFERON; TENOFOVIR; VIRUS DNA; VIRUS RNA;

BLOOD BANK; CHRONIC LIVER DISEASE; DELTA AGENT HEPATITIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; GENOTYPE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS G VIRUS; HEPATITIS GB VIRUS B; HIGH RISK POPULATION; HUMAN; INDIA; INFECTION SENSITIVITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROPREVALENCE; TORQUE TENO VIRUS; VIRUS CARRIER; VIRUS STRAIN; VIRUS TRANSMISSION;

BLOOD DONORS; EPIDEMICS; HEPATITIS, VIRAL, HUMAN; HUMANS; INDIA;

EID: 84862656259     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2012.03.003     Document Type: Review

References (108)

1. Viswanathan R. Epidemiology. Indian J Med Res 1957, 45(Suppl):1-29.
2. Dhamdhere M.R., Nadkarni M.G. Infectious hepatitis at Aurangabad: report of an outbreak. Indian J Med Sci 1962, 16:1006-1015.
3. Bhattacharji L.M., Saha A.L., Sampathkumaran M.A., et al. Investigation of an outbreak of infectious hepatitis in a small town in West Bengal during July-October, 1960. Indian J Med Res 1963, 51:550-562.
4. Pattanayak S., Singha P., Pal S.C., et al. An outbreak of infectious hepatitis in Siliguri, 1966. Indian J Med Res 1968, 56(11):1605-1616.
5. Khuroo M.S. Study of an epidemic of non-A, non-B hepatitis: possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980, 68(6):818-824.
6. Naik S.R., Aggarwal R., Salunke P.N., et al. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 1992, 70(5):597-604.
7. Ray R., Aggarwal R., Salunke P.N., et al. Hepatitis E virus genome in stools of hepatitis patients during large epidemic in north India. Lancet 1991, 338(8770):783-784.
8. Bansal J., He J., Yarbough P.O., et al. Hepatitis E virus infection in eastern India. Am J Trop Med Hyg 1998, 59(2):258-260.
9. Nanda S.K., Yalcinkaya K., Panigrahi A.K., et al. Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol 1994, 42(2):133-137.
10. Madan K., Gopalkrishna V., Kar P., et al. Detection of hepatitis C and E virus genomes in sera of patients with acute viral hepatitis and fulminant hepatitis by their simultaneous amplification in PCR. J Gastroenterol Hepatol 1998, 13(2):125-130.
11. Arankalle V.A., Tsarev S.A., Chadha M.S., et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis 1995, 171(2):447-450.
12. Mohanavalli B., Dhevahi E., Menon T., et al. Prevalence of antibodies to hepatitis A and hepatitis E virus in urban school children in Chennai. Indian Pediatr 2003, 40(4):328-331.
13. Acharya S.K., Batra Y., Bhatkal B., et al. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination. J Gastroenterol Hepatol 2003, 18(7):822-827.
14. Mathur P., Arora N.K. Epidemiological transition of hepatitis A in India: issues for vaccination in developing countries. Indian J Med Res 2008, 128(6):699-704.
15. Tandon B.N., Gandhi B.M., Joshi Y.K. Etiological spectrum of viral hepatitis and prevalence of markers of hepatitis A and B virus infection in north India. Bull World Health Organ 1984, 62(1):67-73.
16. Tandon B.N., Acharya S.K., Tandon A. Epidemiology of hepatitis B virus infection in India. Gut 1996, 38(Suppl 2):S56-S59.
17. Prevention of hepatitis B in India 2002, World Health Organization, World Health Organization Regional Office for South-East Asia, New Delhi.
18. Acharya S.K., Madan K., Dattagupta S., et al. Viral hepatitis in India. Natl Med J India 2006, 19(4):203-217.
19. Arora N.K., Nanda S.K., Gulati S., et al. Acute viral hepatitis types E, A, and B singly and in combination in acute liver failure in children in north India. J Med Virol 1996, 48(3):215-221.
20. Anand A.C., Nagpal A.K., Seth A.K., et al. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?. J Assoc Physicians India 2004, 52:785-787.
21. Dwivedi M., Misra S.P., Misra V., et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol 2011, 30(2):66-71.
22. Prakash C., Sharma R.S., Bhatia R., et al. Prevalence of North India of hepatitis B carrier state amongst pregnant women. Southeast Asian J Trop Med Public Health 1998, 29(1):80-84.
23. Dhawan H.-K., Marwaha N., Sharma R.-R., et al. Anti-HBc screening in Indian blood donors: still an unresolved issue. World J Gastroenterol 2008, 14(34):5327-5330.
24. Asim M., Ali R., Khan L.A., et al. Significance of anti-HBc screening of blood donors & its association with occult hepatitis B virus infection: implications for blood transfusion. Indian J Med Res 2010, 132:312-317.
25. Tandon B.N., Irshad M., Raju M., et al. Prevalence of HBsAg & anti-HBs in children & strategy suggested for immunisation in India. Indian J Med Res 1991, 93:337-339.
26. Nayak N.C., Panda S.K., Zuckerman A.J., et al. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol 1987, 21(2):137-145.
27. Banerjee A., Chakravarty R., Mondal P.N., et al. Hepatitis B virus genotype D infection among antenatal patients attending a maternity hospital in Calcutta, India: assessment of infectivity status. Southeast Asian J Trop Med Public Health 2005, 36(1):203-206.
28. Khakhkhar V., Joshi P.J. HBsAg seropositivity among multi-transfused thalassemic children. Indian J Pathol Microbiol 2006, 49(4):516-518.
29. Ghosh K., Joshi S.H., Shetty S., et al. Transfusion transmitted diseases in haemophilics from western India. Indian J Med Res 2000, 112:61-64.
30. Murthy K.K., John G.T., Abraham P., et al. Profile of hepatitis B and hepatitis C virus infections in dialysis and renal transplant patients 1997-2001; CMCH Vellore. Indian J Nephrol 2003, 13:24-28.
31. Risbud A., Mehendale S., Basu S., et al. Prevalence and incidence of hepatitis B virus infection in STD clinic attendees in Pune, India. Sex Transm Infect 2002, 78(3):169-173.
32. Singh S., Prasad R., Mohanty A. High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India. Int J STD AIDS 1999, 10(7):475-478.
33. Irshad M., Singh Y.N., Acharya S.K. HBV-status in professional blood donors in north India. Trop Gastroenterol 1992, 13(3):112-114.
34. Saha M.K., Chakrabarti S., Panda S., et al. Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India. Indian J Med Res 2000, 111:37-39.
35. Murhekar M.V., Murhekar K.M., Das D., et al. Prevalence of hepatitis B infection among the primitive tribes of Andaman & Nicobar Islands. Indian J Med Res 2000, 111:199-203.
36. Murhekar M.V., Murhekar K.M., Sehgal S.C. Alarming prevalence of hepatitis-B infection among the Jarawas-a primitive Negrito tribe of Andaman and Nicobar Islands, India. J Viral Hepat 2003, 10(3):232-233.
37. Hutin Y.J.F. Acting upon evidence: progress towards the elimination of unsafe injection practices in India. Indian Pediatr 2005, 42(2):111-115.
38. Kermode M., Muani V. Injection practices in the formal & informal healthcare sectors in rural north India. Indian J Med Res 2006, 124(5):513-520.
39. Gandhe S.S., Chadha M.S., Arankalle V.A. Hepatitis B virus genotypes and serotypes in western India: lack of clinical significance. J Med Virol 2003, 69(3):324-330.
40. Vivekanandan P., Abraham P., Sridharan G., et al. Distribution of hepatitis B virus genotypes in blood donors and chronically infected patients in a tertiary care hospital in southern India. Clin Infect Dis 2004, 38(9):e81-e86.
41. Chattopadhyay S., Das B.C., Kar P. Hepatitis B virus genotypes in chronic liver disease patients from New Delhi, India. World J Gastroenterol 2006, 12(41):6702-6706.
42. Banerjee A., Datta S., Chandra P.K., et al. Distribution of hepatitis B virus genotypes: phylogenetic analysis and virological characteristics of genotype C circulating among HBV carriers in Kolkata, Eastern India. World J Gastroenterol 2006, 12(37):5964-5971.
43. Kumar G.T., Kazim S.N., Kumar M., et al. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. J Gastroenterol Hepatol 2009, 24(4):588-598.
44. Arankalle V.A., Gandhe S.S., Borkakoty B.J., et al. A novel HBV recombinant (genotype I) similar to Vietnam/Laos in a primitive tribe in eastern India. J Viral Hepat 2010, 17(7):501-510.
45. Banerjee A., Kurbanov F., Datta S., et al. Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J Med Virol 2006, 78(9):1164-1174.
46. Chandra P.K., Biswas A., Datta S., et al. Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection. J Viral Hepat 2009, 16(10):749-756.
47. Aggarwal R., Ghoshal U.C., Naik S.R. Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries. Natl Med J India 2002, 15(6):320-327.
48. Puri S., Bhatia V., Singh A., et al. Uptake of newer vaccines in Chandigarh. Indian J Pediatr 2007, 74(1):47-50.
49. Mukhopadhyaya A. Hepatitis C in India. J Biosci 2008, 33(4):465-473.
50. Chowdhury A., Santra A., Chaudhuri S., et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003, 37(4):802-809.
51. Nandi J., Bhawalkar V., Mody H., et al. Detection of HIV-1, HBV and HCV antibodies in blood donors from Surat, western India. Vox Sang 1994, 67(4):406-407.
52. Jha J., Banerjee K., Arankalle V.A. A high prevalence of antibodies to hepatitis C virus among commercial plasma donors from Western India. J Viral Hepat 1995, 2(5):257-260.
53. Agarwal M.B., Malkan G.H., Bhave A.A., et al. Antibody to hepatitis-C virus in multi-transfused thalassaemics-Indian experience. J Assoc Physicians India 1993, 41(4):195-197.
54. Jaiswal S.P.B., Chitnis D.S., Jain A.K., et al. Prevalence of hepatitis viruses among multi-transfused homogenous thalassaemia patients. Hepatol Res 2001, 19(3):247-253.
55. Reddy A.K., Murthy K.V.D., Lakshmi V. Prevalence of HCV infection in patients on haemodialysis: survey by antibody and core antigen detection. Indian J Med Microbiol 2005, 23(2):106-110.
56. Radhakrishnan S., Abraham P., Raghuraman S., et al. Role of molecular techniques in the detection of HBV DNA & HCV RNA among renal transplant recipients in India. Indian J Med Res 2000, 111:204-211.
57. Singh S., Dwivedi S.N., Sood R., et al. Hepatitis B, C and human immunodeficiency virus infections in multiply-injected kala-azar patients in Delhi. Scand J Infect Dis 2000, 32(1):3-6.
58. Hoofnagle J.H. Course and outcome of hepatitis C. Hepatology 2002, 36(5 Suppl 1):S21-S29.
59. Ghany M.G., Strader D.B., Thomas D.L., et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49(4):1335-1374.
60. Raghuraman S., Abraham P., Sridharan G., et al. HCV genotype 4-an emerging threat as a cause of chronic liver disease in Indian (south) patients. J Clin Virol 2004, 31(4):253-258.
61. Raghuraman S., Abraham P., Sridharan G., et al. Hepatitis C virus genotype 6 infection in India. Indian J Gastroenterol 2005, 24(2):72-73.
62. Makroo R.N., Choudhury N., Jagannathan L., et al. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus-1 & hepatitis B & C viruses in Indian blood donors. Indian J Med Res 2008, 127(2):140-147.
63. Ince N., Wands J.R. The increasing incidence of hepatocellular carcinoma. N Engl J Med 1999, 340(10):798-799.
64. Dhir V., Mohandas K.M. Epidemiology of digestive tract cancers in India. III. Liver. Indian J Gastroenterol 1998, 17(3):100-103.
65. Wedemeyer H., Manns M.P. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 2010, 7(1):31-40.
66. Hadziyannis S.J. Review: hepatitis delta. J Gastroenterol Hepatol 1997, 12(4):289-298.
67. Casey J.L. Hepatitis delta virus: molecular biology, pathogenesis and immunology. Antivir Ther (Lond) 1998, 3(Suppl 3):37-42.
68. Taylor J.M. Hepatitis delta virus. Intervirology 1999, 42(2-3):173-178.
69. Chakraborty P., Kailash U., Jain A., et al. Seroprevalence of hepatitis D virus in patients with hepatitis B virus-related liver diseases. Indian J Med Res 2005, 122(3):254-257.
70. Irshad M., Sharma Y., Dhar I., et al. Transfusion-transmitted virus in association with hepatitis A-E viral infections in various forms of liver diseases in India. World J Gastroenterol 2006, 12(15):2432-2436.
71. Saravanan S., Velu V., Kumarasamy N., et al. Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India. Trans R Soc Trop Med Hyg 2008, 102(8):793-796.
72. Chandra V., Taneja S., Kalia M., et al. Molecular biology and pathogenesis of hepatitis E virus. J Biosci 2008, 33(4):451-464.
73. Ramachandran J., Ramakrishna B., Eapen C.E., et al. Subacute hepatic failure due to hepatitis E. J Gastroenterol Hepatol 2008, 23(6):879-882.
74. Khuroo M.S., Teli M.R., Skidmore S., et al. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981, 70(2):252-255.
75. Patra S., Kumar A., Trivedi S.S., et al. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007, 147(1):28-33.
76. Pal R., Aggarwal R., Naik S.R., et al. Immunological alterations in pregnant women with acute hepatitis E. J Gastroenterol Hepatol 2005, 20(7):1094-1101.
77. Prusty B.K., Hedau S., Singh A., et al. Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Mol Med 2007, 13(9-10):518-526.
78. Khuroo M.S., Kamili S., Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995, 345(8956):1025-1026.
79. Khuroo M.S., Kamili S., Yattoo G.N. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004, 19(7):778-784.
80. Somani S.K., Aggarwal R., Naik S.R., et al. A serological study of intrafamilial spread from patients with sporadic hepatitis E virus infection. J Viral Hepat 2003, 10(6):446-449.
81. Hamid S.S., Atiq M., Shehzad F., et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002, 36(2):474-478.
82. Ramachandran J., Eapen C.E., Kang G., et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol 2004, 19(2):134-138.
83. Kamar N., Selves J., Mansuy J.-M., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008, 358(8):811-817.
84. Kumar A., Yachha S.K., Poddar U., et al. Does co-infection with multiple viruses adversely influence the course and outcome of sporadic acute viral hepatitis in children?. J Gastroenterol Hepatol 2006, 21(10):1533-1537.
85. Huang F.F., Sun Z.F., Emerson S.U., et al. Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV. J Gen Virol 2004, 85(Pt 6):1609-1618.
86. Arankalle V.A., Paranjape S., Emerson S.U., et al. Phylogenetic analysis of hepatitis E virus isolates from India (1976-1993). J Gen Virol 1999, 80(Pt 7):1691-1700.
87. Shukla P., Chauhan U.K., Naik S., et al. Hepatitis E virus infection among animals in northern India: an unlikely source of human disease. J Viral Hepat 2007, 14(5):310-317.
88. Chauhan A., Jameel S., Dilawari J.B., et al. Hepatitis E virus transmission to a volunteer. Lancet 1993, 341(8838):149-150.
89. Shrestha M.P., Scott R.M., Joshi D.M., et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007, 356(9):895-903.
90. Kar P., Bedi P., Berry N., et al. Hepatitis G virus (HGV) infection in voluntary and commercial blood donors in India. Diagn Microbiol Infect Dis 2000, 38(1):7-10.
91. Panigrahi A.K., Saxena A., Acharya S.K., et al. Hepatitis G virus in multitransfused thalassaemics from India. J Gastroenterol Hepatol 1998, 13(9):902-906.
92. Abraham P., John G.T., Raghuraman S., et al. GB virus C/hepatitis G virus and TT virus infections among high risk renal transplant recipients in India. J Clin Virol 2003, 28(1):59-69.
93. Kapoor S., Gupta R.K., Das B.C., et al. Clinical implications of hepatitis G virus (HGV) infection in patients of acute viral hepatitis & fulminant hepatic failure. Indian J Med Res 2000, 112:121-127.
94. Asim M., Singla R., Gupta R.K., et al. Clinical & molecular characterization of human TT virus in different liver diseases. Indian J Med Res 2010, 131:545-554.
95. Uppal Y., Garg S., Mishra B., et al. Prevalence of reproductive morbidity among males in an urban slum in north India. Indian J Comm Med 2007, 32(1):54-57.
96. Chowdhury A., Santra A., Chakravorty R., et al. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen negative infection and associated viral variants. J Gastroenterol Hepatol 2005, 20(11):1712-1720.
97. Bhagyalaxmi A., Lala M.K., Jain S., et al. HBsAg carrier status in urban population of Ahmedabad city. Indian J Med Res 2005, 121:203-204.
98. Singh J., Bhatia R., Khare S., et al. Community studies on prevalence of HBsAg in two urban populations of southern India. Indian Pediatr 2000, 37(2):149-152.
99. Kurien T., Thyagarajan S.P., Jeyaseelan L., et al. Community prevalence of hepatitis B infection and modes of transmission in Tamil Nadu, India. Indian J Med Res 2005, 121:670-675.
100. Nanu A., Sharma S.P., Chatterjee K., et al. Markers of transfusion-tranmissible infections in north Indian voluntary and replacement blood donors: prevalence and trends 1989-1996. Vox Sang 1997, 73:70-73.
101. Pahuja S., Sharma M., Baitha B., et al. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors. A hospital based study Jpn J Inf Dis 2007, 60:689-691.
102. Meena M., Jindal T., Hazarika A. Prevalence of hepatitis B virus and hepatitis C virus among blood donors in a tertiary care hospital in India: a five-year study. Transfusion 2011, 51:198-202.
103. Das B.K., Gayen B.K., Aditya S., et al. Seroprevalence of Hepatitis B, Hepatitis C and human immunodeficiency virus among healthy voluntary first-time blood donors in Kolkata. Ann Trop Med Public Health 2011, 4:86-90.
104. Elavia A.J., Banker D.D. Prevalence of HBsAg and its subtypes in high risk subjects and voluntary blood donors in Bombay Indian. J Med Res 1991, 93:280-285.
105. SatoskarA, Ray V. Prevalence of hepatitis B surface antigen (HBsAg) in blood donors from Bombay. Trop Geogr Med 1992, 44:119-121.
106. Nijhawan S., Rai R.R., Sharma D., et al. HBsAg prevalence in blood donors in Jaipur. Indian J Gastroenterol 1997, 16:162.
107. Singhvi A., Pulimood R.B., John T.J., et al. The prevalence of markers for hepatitis B and human immunodeficiency viruses, malarial parasites and microfilaria in blood donors in a large hospital in south India. J Trop Med Hyg 1990, 93:178-182.
108. Singh K., Bhat S., Shastry S. Trend in seroprevalence of Hepatitis B virus infection among blood donors of coastal Karnataka, India. J Infect Dev Ctries 2009, 3(5):3376-3379.